Multicenter phase II study of oral capecitabine (Xeloda) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. - Reichardt,P.; Minckwitz,G.; Thuss-Patience,P.C. (Ann Oncol, 2003)